PCM
ARVN icon

Prelude Capital Management’s Arvinas ARVN Stock Holding History

Prelude Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,045
Closed -$81.3K – 1142
2025
Q2 		$81.3K Sell
11,045
-52,695
-83% -$388K 0.01% 934
2025
Q1 		$447K Sell
63,740
-1,660
-3% -$26K 0.03% 547
2024
Q4 		$1.25M Buy
+65,400
New +$1.59M 0.08% 320
2024
Q3 		– Sell
-19,607
Closed -$522K – 1268
2024
Q2 		$522K Buy
+19,607
New +$625K 0.04% 530
2021
Q4 		– Sell
-3,251
Closed -$267K – 1975
2021
Q3 		$267K Sell
3,251
-3,499
-52% -$309K 0.01% 1199
2021
Q2 		$520K Buy
6,750
+600
+10% +$41.7K 0.02% 921
2021
Q1 		$407K Sell
6,150
-1,250
-17% -$95.6K 0.01% 996
2020
Q4 		$628K Buy
7,400
+3,271
+79% +$113K 0.02% 636
2020
Q3 		$97K Sell
4,129
-471
-10% -$13.7K ﹤0.01% 920
2020
Q2 		$154K Buy
+4,600
New +$195K 0.01% 813
2019
Q3 		– Sell
-166
Closed -$4K – 1695
2019
Q2 		$4K Buy
+166
New +$3.49K ﹤0.01% 1533

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Prelude Capital Management's ARVN Position: Q3 2025 in Review

Prelude Capital Management sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 11,045 shares — an estimated $81.3K sold.

Prelude Capital Management first reported a position in ARVN in Q2 2019 and held it in 11 quarters. The position peaked at $1.25M in Q4 2024. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

  • Prelude Capital Management reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
  • Prelude Capital Management sold 11,045 Arvinas shares in Q3 2025, an estimated $81.3K.
  • Prelude Capital Management first reported a position in Arvinas in Q2 2019 and held it in 11 quarters.
  • Prelude Capital Management's Arvinas position peaked at $1.25M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.